Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1574]

BrECADD combined with PET2-guided treatment sets a new benchmark for the...

Dr Peter Borchmann - University Hospital Cologne, Cologne, Germany

BrECADD combined with PET2-guided treatment sets a new benchmark for the treatment of newly diagnosed advanced-stage cHL ( Dr Peter Borchmann - University Hospital Cologne, Cologne, Germany )

SABCS 2023: Latest breast cancer diagnostics guidelines

Prof Nadia Harbeck and Prof Giuseppe Curigliano

SABCS 2023: Latest breast cancer diagnostics guidelines ( Prof Nadia Harbeck and Prof Giuseppe Curigliano )

Introducing oncology to undergraduate medical and allied health sciences...

Dr Soumitra Shankar Datta - Tata Medical Center, Kolkata, India

Introducing oncology to undergraduate medical and allied health sciences students ( Dr Soumitra Shankar Datta - Tata Medical Center, Kolkata, India )

Low-dose olanzapine after highly emetogenic chemotherapy can be the new...

Dr Jyoti Bajpai - Tata Memorial Centre, Mumbai, India

Low-dose olanzapine after highly emetogenic chemotherapy can be the new standard of care for solid tumours ( Dr Jyoti Bajpai - Tata Memorial Centre, Mumbai, India )

First-line chemotherapy with atezolizumab and bevacizumab significantly...

Dr Ana Oaknin - Vall d´Hebron Institute of Oncology, Barcelona, Spain

First-line chemotherapy with atezolizumab and bevacizumab significantly improves survival for R/M cervical cancer ( Dr Ana Oaknin - Vall d´Hebron Institute of Oncology, Barcelona, Spain )

Special issue on real world breast cancer data

Dr Siddhartha Kar - University of Cambridge, Cambridge, UK

Special issue on real world breast cancer data ( Dr Siddhartha Kar - University of Cambridge, Cambridge, UK )

Chairperson: Evidence Communication

Dr Hemant Malhotra - Sriram Cancer Center of the Mahatma Gandhi College...

Chairperson: Evidence Communication ( Dr Hemant Malhotra - Sriram Cancer Center of the Mahatma Gandhi College Hospital, Jaipur, India )

Patient benefit vs industry benefit finding a balance

Dr Bishal Gyawali - Queen's University, Kingston, Canada

Patient benefit vs industry benefit finding a balance ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )

Haemato-oncological Cancers

Dr Nikita Mehra - Cancer Institute (WIA), Chennai, India

Haemato-oncological Cancers ( Dr Nikita Mehra - Cancer Institute (WIA), Chennai, India )

Shared decision making (Patient-oncologist)

Dr Don Dizon - Brown University, Boston, USA

Shared decision making (Patient-oncologist) ( Dr Don Dizon - Brown University, Boston, USA )

Panelist - Patient Advocacy Panel discussion

Dr Sheela Rao - The Royal Marsden NHS Foundation Trust, London, UK

Panelist - Patient Advocacy Panel discussion ( Dr Sheela Rao - The Royal Marsden NHS Foundation Trust, London, UK )

Patient advocacy – the right communication

Dr Geeta Kadayaprath - Max Super Speciality Hospital, Delhi, India

Patient advocacy – the right communication ( Dr Geeta Kadayaprath - Max Super Speciality Hospital, Delhi, India )

More from ecancer